Pending EO 12866 Regulatory Review

RIN: 0910-ZC67	Received Date: 11/26/2025
Title: New and Revised Draft Q&As on Biosimilar Development and the Biologics Price Competition and Innovation Act; Draft Guidance for Industry; Availability
Agency/Subagency: HHS / FDA	Stage: Notice
Legal Deadline: None	Economically Significant: No
International Impacts: Yes	Affordable Care Act [Pub. L. 111-148 & 111-152]: Yes
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No